The rising prevalence of chronic & infectious diseases is expected to drive the demand for DTC laboratory testing. Many DTC laboratory testing companies are offering tests for diagnosing infectious diseases and monitoring chronic diseases. China has the world’s largest population, with about 1.45 billion people as of 2023. The sheer large population of the country leads to high demand for various healthcare services, including DTC Laboratory services. The geriatric population is also estimated to reach 225 million in 2030 from 170 million in 2020. The elderly population is more prone to chronic and infectious diseases due to immune dysfunction, malnutrition, and aging-related physiological changes. The rising disease burden can directly affect a country’s social and economic status. Thus, it is necessary to adopt early diagnostic procedures to minimize the burden of these diseases. The large population, the rise in the geriatric population, and the rising prevalence of diseases have led to increased demand for DTC Laboratory testing. Thus, the advantages of DTC lab testing, such as discretion & confidentiality and the increased prevalence of sexually transmitted diseases, are expected to drive the demand for DTC lab testing.